William Farrar B MD

William Farrar B MD
ProfessorCollege of Medicinefarrar.2@osu.edu
N924 Doan Hall 410 W 10th Avenue Columbus Ohio 43210
Phone:614-293-8890Fax: (614) 293-3465
  • Molecular Carcinogenesis and Chemoprevention

Research Description

Dr. Farrar's research interests include the study bioactive food components with cancer-preventative properties and to examine key epigenetic processes in order to begin to establish linkages between epigenetics, methylation patterns, and tumor incidences/behaviors.

Current Publications

  • Chao AH, Khansa I, Farrar WB, Miller MJProcess Outcomes in Breast Reconstruction and the Impact of a Comprehensive Breast Center.Plast Reconstr Surg 134 94 10/1/2014
  • Fagundes CP, Jaremka LM, Glaser R, Alfano CM, Povoski SP, Lipari AM, Agnese DM, Yee LD, Carson WE 3rd, Farrar WB, Malarkey WB, Chen M, Kiecolt-Glaser JKAttachment anxiety is related to Epstein-Barr virus latency.Brain Behav Immun 41 232-8 10/1/2014
  • Jaremka LM, Andridge RR, Fagundes CP, Alfano CM, Povoski SP, Lipari AM, Agnese DM, Arnold MW, Farrar WB, Yee LD, Carson WE, Bekaii-Saab T, Martin EW, Schmidt CR, Kiecolt-Glaser JKPain, depression, and fatigue: Loneliness as a longitudinal risk factor.Health Psychol 33 948-57 9/1/2014
  • Wu SM, Brothers BM, Farrar W, Andersen BLIndividual Counseling is the Preferred Treatment for Depression in Breast Cancer Survivors.J Psychosoc Oncol in press 0 8/26/2014
  • Jaremka LM, Peng J, Povoski SP, Lipari AM, Agnese DM, Farrar WB, Yee LD, Carson WE 3rd, Bornstein R, Alfano CM, Andridge RR, Kiecolt-Glaser JKCognitive problems among breast cancer survivors: loneliness enhances risk.Psychooncology in press 4/11/2014
  • Gradishar WJ, Anderson BO, Blair SL, Burstein HJ, Cyr A, Elias AD, Farrar WB, Forero A, Giordano SH, Goldstein LJ, Hayes DF, Hudis CA, Isakoff SJ, Ljung BM, Marcom PK, Mayer IA, McCormick B, Miller RS, Pegram M, Pierce LJ, Reed EC, Salerno KE, Schwartzberg LS, Smith ML, Soliman H, Somlo G, Ward JH, Wolff AC, Zellars R, Shead DA, Kumar RBreast cancer version 3.2014.J Natl Compr Canc Netw 12 542-90 4/1/2014
  • Hughes S, Jaremka LM, Alfano CM, Glaser R, Povoski SP, Lipari AM, Agnese DM, Farrar WB, Yee LD, Carson WE 3rd, Malarkey WB, Kiecolt-Glaser JKSocial support predicts inflammation, pain, and depressive symptoms: longitudinal relationships among breast cancer survivors.Psychoneuroendocrinology 42 38-44 4/1/2014
  • Robidoux A, Tang G, Rastogi P, Geyer CE Jr, Azar CA, Atkins JN, Fehrenbacher L, Bear HD, Baez-Diaz L, Sarwar S, Margolese RG, Farrar WB, Brufsky AM, Shibata HR, Bandos H, Paik S, Costantino JP, Swain SM, Mamounas EP, Wolmark NLapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial.Lancet Oncol 14 1183-92 11/1/2013
  • Lindgren ME, Fagundes CP, Alfano CM, Povoski SP, Agnese DM, Arnold MW, Farrar WB, Yee LD, Carson WE, Schmidt CR, Kiecolt-Glaser JKBeta-blockers may reduce intrusive thoughts in newly diagnosed cancer patients.Psychooncology 22 1889-94 8/1/2013
  • Theriault RL, Carlson RW, Allred C, Anderson BO, Burstein HJ, Edge SB, Farrar WB, Forero A, Giordano SH, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Isakoff SJ, Ljung BM, Mankoff DA, Marcom PK, Mayer IA, McCormick B, Pierce LJ, Reed EC, Schwartzberg LS, Smith ML, Soliman H, Somlo G, Ward JH, Shead DA, Kumar R, National Comprehensive Cancer Network, Wolff AC, Zellars RBreast cancer, version 3.2013: featured updates to the NCCN guidelines.J Natl Compr Canc Netw 11 753-60; quiz 761 7/1/2013

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 300 W. 10th Ave. Columbus, OH 43210 Phone: 1-800-293-5066 | Email: jamesline@osumc.edu